# FDA Inspection 1303280 - ADMA BioCenters Georgia Inc - February 06, 2026

Source: https://www.keypedia.com/records/fda_inspections/adma-biocenters-georgia-inc/12003926-eb25-481d-8e20-72c4e92c475d
Source feed: FDA_Inspections

> FDA Inspection 1303280 for ADMA BioCenters Georgia Inc on February 06, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303280
- Company Name: ADMA BioCenters Georgia Inc
- Inspection Date: 2026-02-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294328 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/adma-biocenters-georgia-inc/e50a4346-699f-4632-8ef1-34c58bc8e9d8)
- [FDA Inspection 1241184 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/adma-biocenters-georgia-inc/b8d3361b-fec5-427a-b3fa-aa4092816cb7)

Company: https://www.keypedia.com/companies/adma-biocenters-georgia-inc/f8c0ff94-012e-42c4-b585-1df39774d488

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d